CENTOGENE Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test
02 juil. 2020 08h03 HE
|
CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 02, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress
15 juin 2020 06h30 HE
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 15, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
CENTOGENE Marks Rare Disease Day 2020 With a Global Line up of Events
29 févr. 2020 00h00 HE
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 29, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical...
CentoMD® Update Reveals Continued Growth of Rare Hereditary Disease Knowledge Base
16 déc. 2019 06h37 HE
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany, Dec. 16, 2019 (GLOBE NEWSWIRE) -- In an update released today by CENTOGENE (Nasdaq: CNTG) to CentoMD® - the Company’s data repository of epidemiologic,...
CENTOGENE Expands Executive Leadership Team
06 déc. 2019 06h00 HE
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany, Dec. 06, 2019 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG) today announced the expansion of its executive leadership team with the appointment of Philip...
Centogene reporting its financial results for the three months and nine months ended September 30, 2019
05 déc. 2019 06h28 HE
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 05, 2019 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
CENTOGENE to Announce Third Quarter 2019 Financial Results on 5th December 2019
02 déc. 2019 03h00 HE
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 02, 2019 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
CENTOGENE Announces Temporary Leave of Absence of Holger Friedrich from the Supervisory Board
21 nov. 2019 08h54 HE
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 21, 2019 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical...
CENTOGENE Signs New Collaboration with PTC Therapeutics for Global Diagnostic Testing Program
18 nov. 2019 08h00 HE
|
Centogene AG
CAMBRIDGE, Ma. and ROSTOCK, Germany, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Centogene N.V. (NASDAQ: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and...
CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc.
13 nov. 2019 03h23 HE
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 13, 2019 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical...